These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2454067)

  • 41. Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.
    Okada H; Kalinski P; Ueda R; Hoji A; Kohanbash G; Donegan TE; Mintz AH; Engh JA; Bartlett DL; Brown CK; Zeh H; Holtzman MP; Reinhart TA; Whiteside TL; Butterfield LH; Hamilton RL; Potter DM; Pollack IF; Salazar AM; Lieberman FS
    J Clin Oncol; 2011 Jan; 29(3):330-6. PubMed ID: 21149657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomas.
    Butowski N; Lamborn KR; Lee BL; Prados MD; Cloughesy T; DeAngelis LM; Abrey L; Fink K; Lieberman F; Mehta M; Ian Robins H; Junck L; Salazar AM; Chang SM
    J Neurooncol; 2009 Jan; 91(2):183-9. PubMed ID: 18850068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimization of an immunotherapeutic protocol with poly(I,C)-LC.
    Talmadge JE; Hartmann D
    J Biol Response Mod; 1985 Oct; 4(5):484-9. PubMed ID: 4078594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunochemotherapy for Leishmania donovani infection in golden hamsters: combinatorial action of poly ICLC plus L-arginine and sodium stibogluconate (Stibanate).
    Bhakuni V; Kulkarni S; Ali V; Singh UK; Levy HB; Maheshwari RK
    J Interferon Cytokine Res; 1999 Oct; 19(10):1103-6. PubMed ID: 10547149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of interferon on rabies infection of animals.
    Baer GM
    Tex Rep Biol Med; 1981-1982; 41():526-31. PubMed ID: 6189218
    [No Abstract]   [Full Text] [Related]  

  • 46. Recurrent respiratory papillomatosis.
    Leventhal BG; Whisnant J; Kashima H; Levy H; Biggers WP
    J Biol Response Mod; 1985 Oct; 4(5):525-30. PubMed ID: 4078597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferons and interferon inducers in cancer treatment.
    Krown SE
    Semin Oncol; 1986 Jun; 13(2):207-17. PubMed ID: 2424089
    [No Abstract]   [Full Text] [Related]  

  • 48. Phase I trials of poly(I,C) complexes in advanced cancer.
    Krown SE; Kerr D; Stewart WE; Field AK; Oettgen HF
    J Biol Response Mod; 1985 Dec; 4(6):640-9. PubMed ID: 2418162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of interferon in blood, cerebrospinal fluid, and brain after administration of modified polyriboinosinic-polyribocytidylic acid and amphotericin B.
    Williams BB; Paul RT; Lerner AM
    J Infect Dis; 1982 Dec; 146(6):819-25. PubMed ID: 6183371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.
    Ewel CH; Urba WJ; Kopp WC; Smith JW; Steis RG; Rossio JL; Longo DL; Jones MJ; Alvord WG; Pinsky CM
    Cancer Res; 1992 Jun; 52(11):3005-10. PubMed ID: 1591717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunotherapy of metastatic renal cell carcinoma with polyinosinic-polycytidylic acid.
    Droller MJ
    J Urol; 1987 Feb; 137(2):202-6. PubMed ID: 3806804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poly ICLC in the treatment of postinfectious demyelinating encephalomyelitis.
    Salazar AM; Engel WK; Levy HB
    Arch Neurol; 1981 Jun; 38(6):382-3. PubMed ID: 7236070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy of poly-ICLC against Ebola-Zaire virus (EBOV) infection in mice and cynomolgus monkeys.
    Kende M; Paragas J; Salazar AM
    Antiviral Res; 2019 Mar; 163():179-184. PubMed ID: 30611774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer.
    Dillon PM; Petroni GR; Smolkin ME; Brenin DR; Chianese-Bullock KA; Smith KT; Olson WC; Fanous IS; Nail CJ; Brenin CM; Hall EH; Slingluff CL
    J Immunother Cancer; 2017 Nov; 5(1):92. PubMed ID: 29157306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune response modifying activity in mice of polyinosinic: polycytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly-ICLC].
    Chirigos MA; Papademetriou V; Bartocci A; Read E; Levy HB
    Int J Immunopharmacol; 1981; 3(4):329-37. PubMed ID: 7333719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex [poly(ICL)] without carboxymethylcellulose (CMC): a new primate-effective interferon inducer.
    Riley FL; Morin ML; Lvovsky E; Stephens EE; Levy HB
    Proc Soc Exp Biol Med; 1982 Feb; 169(2):183-8. PubMed ID: 6174989
    [No Abstract]   [Full Text] [Related]  

  • 57. Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.
    Sammons ML; Stephen EL; Levy HB; Baron S; Hilmas DE
    Antimicrob Agents Chemother; 1977 Jan; 11(1):80-3. PubMed ID: 402107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of treatment with exogenous interferon, polyriboinosinic-polyribocytidylic acid, or polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex on Herpesvirus hominis infections in mice.
    Olsen GA; Kern ER; Overall JC
    J Infect Dis; 1978 Apr; 137(4):428-36. PubMed ID: 206632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The protective effect of polyriboinosinic acid-polyribocytidylic acid against the occurrence of galactosamine-induced liver cell injury in rat.
    Sakakibara S; Shibayama Y; Ueda I; Kagamiyama H
    Experientia; 1983 Feb; 39(2):174-6. PubMed ID: 6832294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phase II trial of poly(I,C)-LC, an interferon inducer, in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group.
    Lampkin BC; Levine AS; Levy H; Krivit W; Hammond D
    J Biol Response Mod; 1985 Oct; 4(5):531-7. PubMed ID: 2416884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.